CohBar Competitors and Similar CompaniesClear all
CohBar's competitors and similar companies include Novartis, Pfizer and Fortrea.
 CohBar CohBar is a clinical-stage biotechnology company focused on the research and development of mitochondria based therapeutics. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | |
Founding Date | Founding Date 2007 | Founding Date 1996 | Founding Date 1849 | Founding Date 2023 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Menlo Park, US HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more |
Employees | Employees 918% decrease | Employees 75,883 | Employees 81,0008% decrease | Employees 19,000 |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 1.6 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ($12.2m) (FY, 2022) | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income ($986.2m) (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries N/A | Countries 200 (FY, 2024) | Countries 90 (Jul, 2023) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 450k | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyFortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company